Skip to main content
Clinical Trials/NCT01045174
NCT01045174
Terminated
Not Applicable

A Randomized Controlled Trial Comparing the Effectiveness of a Breath-Actuated Nebulizer Device Versus a Conventional Continuous-Output Nebulizer in Treating Pediatric Asthma Patients in the Emergency Department

University Hospitals Cleveland Medical Center1 site in 1 country180 target enrollmentDecember 2008
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
University Hospitals Cleveland Medical Center
Enrollment
180
Locations
1
Primary Endpoint
Rate of Admission to Hospital for Asthma Exacerbation
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

A Breath-Actuated Nebulizer is a newer type of nebulizer device that creates aerosol only when a patient is inhaling, rather than creating aerosol continuously. It is thought that breath-actuated nebulizer devices may deliver asthma rescue medications to patients' lungs more effectively and therefore lead them to recover from asthma attacks faster than conventional continuous-output nebulizer devices. This study compares outcomes including hospital admission rates, number of nebulized treatments required, and patient/family satisfaction when a breath-actuated nebulizer device versus a conventional continuous-output nebulizer is used to deliver asthma medications to pediatric asthma patients in the emergency department.

Registry
clinicaltrials.gov
Start Date
December 2008
End Date
December 2010
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jerri A. Rose

M.D.

University Hospitals Cleveland Medical Center

Eligibility Criteria

Inclusion Criteria

  • children 1-17 years old with known history of asthma
  • children must be presenting to the emergency department for treatment of acute asthma
  • children must qualify to be treated for acute asthma according to an existing standardized asthma care algorithm

Exclusion Criteria

  • concomitant chronic respiratory or cardiac disease such as cystic fibrosis, congenital heart disease, or bronchopulmonary dysplasia
  • no prior history of asthma
  • pregnancy
  • reported history of drug allergy to albuterol or ipratropium bromide
  • previous participation in the study within the preceding three weeks
  • vital sign instability/need for immediate emergency intervention to prevent clinical deterioration

Outcomes

Primary Outcomes

Rate of Admission to Hospital for Asthma Exacerbation

Time Frame: 24 hours (whether patient is admitted after presenting to emergency department for asthma or discharged home)

Number (and percentage) of children in each study group requiring admission to the hospital for asthma exacerbation/status asthmaticus from the Pediatric Emergency Department (as opposed to being discharged to home)

Secondary Outcomes

  • Difficulty (if Any) Encountered by Patients With Using Assigned Nebulizer Device(number of children who had difficulty using assigned nebulizer device during the timeframe of the ED visit during which the study nebulizer was used. Timeframe for outcome measure was length of single emergency department visit, up to 400 minutes.)
  • Length of Stay in the Emergency Department After Presenting for Asthma Exacerbation(only measures length of stay in emergency department on date of presentation)
  • Patient's Satisfaction With Using Assigned Nebulizer (as Assessed by Brief Survey)(within time frame of emergency department stay (up to 400 minutes from initial presentation to pediatric ED))

Study Sites (1)

Loading locations...

Similar Trials